Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
نویسندگان
چکیده
Acromegaly is a rare disease with an estimated incidence of 2.5 cases per million (cpm) per year according to Spanish national data. In 1997 the Spanish Acromegaly Registry (Registro Español de Acromegalia [REA]) was set up. The main objective of the project was to collect epidemiological, clinical and biochemical data, as well as data on treatments and outcomes of acromegaly in Spain. Data entry was prospective and retrospective. Peak data entry was recorded between 1998 and 1999, and declined thereafter. In 2004 data were analyzed and the results were published in the European Journal of Endocrinology. Twelve years after the database was set up, the neuroendocrine group of the Spanish Society of Endocrinology and Nutrition (Sociedad Española de Endocrinologı́a y Nutrición [SEEN]) urged for new data entry, updating of previous patients and new data analysis. The main aim of the project is to define trends in acromegaly treatment and outcomes in Spain. We also aim to provide mortality data
منابع مشابه
[Epidemiology of acromegaly in Spain].
Epidemiology of acromegaly in Spain does not differ from that reported in other published series. Prevalence rate is approximately 60 cases per million, peak incidence occurs in middle age, more women are affected (61%), and there is a substantial delay between occurrence of the first symptoms and diagnosis. Studies REA (Spanish Acromegaly Registry) and OASIS analyzed the epidemiology, clinical...
متن کاملEpidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).
OBJECTIVE To undertake a multicentre epidemiological study reflecting acromegaly in Spain. DESIGN Voluntary reporting of data on patients with acromegaly to an online database, by the managing physician. METHODS Data on demographics, diagnosis, estimated date of initial symptoms and diagnosis, pituitary imaging, visual fields, GH and IGF-I concentrations (requested locally), medical, radiot...
متن کاملگزارش یک مورد: آکرومگالی و بروز سرطان پستان در یک مرد
Abstract: Background: Acromegaly is due to excess of growth hormone production and imbalance of cell growth which leads to somatic manifestations and organ dysfunction. With increasing life span an increasing incidence of colorectal, breast, and blood cancers is seen. In this paper we report a 57 year old male with acromegaly he had developed a swelling in the right breast for the last 2 yea...
متن کاملThe Combination Therapy with Bromocriptine and Cyproheptadine in Patients with Acromegaly
The therapeutic efficacy of the combination of cyproheptadine and bromocriptine was studied in 15 patients with active acromegaly showing incomplete GH suppression in response to bromocriptine therapy alone. The mean basal plasma GH was 31.3±5.5 µg/L, and it decreased to 19.0±3.9 µg/L during the single bromocriptine therapy (10-20 mg for 2 to 21 months). When cyproheptadine (12 to 16 mg for 8 t...
متن کاملAcromegaly according to the Danish National Registry of Patients: how valid are ICD diagnoses and how do patterns of registration affect the accuracy of registry data?
BACKGROUND The incidence of acromegaly is uncertain, since population-based studies are few. In the absence of a specific acromegaly registry, the Danish National Registry of Patients (DNRP) becomes a potential source of data for studying the epidemiology of acromegaly, by linking all hospital discharge diagnoses to the personal identification numbers of individual Danish inhabitants. The valid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
دوره 57 2 شماره
صفحات -
تاریخ انتشار 2010